So it wasn’t ‘by the book’? Strzok notes reveal Obama & Biden were involved in FBI going after General Flynn
RT | June 24, 2020
New evidence shows that the decision to send the FBI after General Michael Flynn, president-elect Donald Trump’s top adviser, came from President Barack Obama and Vice President Joe Biden and wasn’t “by the book” at all.
Biden was the one to raise the Logan Act, while Obama instructed FBI Director James Comey and Deputy Attorney General Sally Yates to have “the right people” on the case during a White House meeting, according to a handwritten note from FBI Agent Peter Strzok.
The note was provided by the DOJ earlier this week to Flynn’s attorneys, who submitted it to the court as evidence on Wednesday.
While Strzok’s hard-to-read note does not mention names, it refers to people by letters – P for president, VP for vice-president, DAG for Yates, D for Director Comey, etc. – according to the court filing.
The Logan Act is an old law that bans private citizens from conducting foreign policy, but it did not apply to Flynn, since he was an incoming national security adviser to the president-elect. Even Comey admitted that his telephone conversations with Russian Ambassador Sergey Kislyak “appear legit[imate],” but was nonetheless told to pursue a case, according to Strzok’s note.
This directly contradicts the narrative about the meeting put forth by Obama’s security adviser Susan Rice, who wrote a strange memo to herself on the eve of Trump’s inauguration repeatedly saying that Obama wanted the investigation to be “by the book.”
Strzok’s note is undated, but the filing says it appears to be referring to a meeting on January 4, 2017 – the same date Strzok intervened to keep the FBI background case against Flynn open, though it had been scheduled to close due to lack of evidence of any wrongdoing. Strzok would later be one of the agents to interview Flynn, and admitted in texts to heavily editing the memorandum of that interview – which has not been made available as evidence.
Earlier in the day, the Washington, DC Circuit Court of Appeals ordered the federal judge in charge of Flynn’s case to immediately agree to the government motion to drop the charges. Last month, Judge Emmet Sullivan responded to the DOJ motion to dismiss charges – in light of evidence revealing the prosecution of Flynn was improperly predicated – by appointing a hostile ex-judge to evaluate the motion and hiring a private attorney to represent himself, at taxpayers’ expense. Flynn’s team reacted by seeking a writ of mandamus from the appeals court.
Flynn was the first casualty of the ‘Russiagate’ probe targeting Trump for alleged “collusion” with Russia in the 2016 election. The adviser was forced to resign after less than two weeks on the job, after the Washington Post accused him of lying to the FBI based on yet-unidentified leaks. He was charged by Special Counsel Robert Mueller in late 2017, and pleaded guilty to lying to the FBI under pressure, but has been fighting the charges after getting a new legal counsel in 2018.
President Trump reacted to the news by wondering if Comey and the FBI, or Mueller and his prosecutors, or Obama and Biden, will apologize to Flynn and others caught up in the probe.
Mueller’s investigation ended in May 2019 finding no evidence of any collusion anywhere, forcing Democrats to claim Trump had abused power by withholding aid from Ukraine as a pretext to impeach him.
If black lives matter, then why are African leaders with a different take on Covid-19 being taunted?

Tanzanian President John Pombe Magufuli © AFP / Michele Spatari
By Neil Clark | RT | June 24, 2020
The criticism of Tanzania’s and Madagascar’s presidents, John Magufuli and Andry Rajoelina, for challenging the Covid ‘consensus’ shows that, for some, Black Lives Matter counts only if black voices are saying the ‘right’ things.
YouTube has ‘Black Lives Matter’ as its Twitter bio. Pretty worthy, eh? But that didn’t stop the internet platform removing a video made by a Canadian activist who calls herself ‘Amazing Polly’ that featured claims made about Covid-19 and its treatment by the leaders of Tanzania and Madagascar. It has subsequently restored it, but the fact it took it down in the first place, alongside the sneering, hostile reaction from others to what the African leaders said, speaks volumes about the double standards currently on display.
Magufuli’s great crime was that he decided to test the testers. He instructed his country’s security services to send to Covid-19 testing labs samples taken from a pawpaw, a goat, some engine oil and a type of bird called a kware, among other non-human sources, but to assign them human names and ages. The pawpaw sample was given the name ‘Elizabeth Ane, 26 years, female.’ And guess what? The sample came back positive for Covid-19. As did those from the kware and the goat.
The testing kits had been imported from abroad. Clearly, as Magufuli – a PhD in chemistry – stated, something wasn’t quite right. “When you notice something like this, you must know there’s a dirty game played in those tests,” he said.
He advised his people, in relation to his government’s Covid-19 strategy, “Let us put God first. We must not be afraid of each other” – in stark contrast to the ‘Social distancing is here to stay’ Project Fear approach adopted elsewhere.
Magufuli also assured his people he would be sending a plane to collect an herbal cure for Covid-19 that was being promoted by Madagascar’s President Andry Rajoelina.
In her video, Amazing Polly not only includes extracts of speeches by the leaders of Magufuli and Rajoelina, but also focuses on the criticism they received from the global health establishment.
The subtext: How dare these uppity Africans challenge what we say! How dare they promote their own traditional medicines (instead of Big Pharma’s) or claim coronavirus tests are returning false positives!
“Caution must be taken about misinformation, especially on social media, about the effectiveness of certain remedies,” declared the World Health Organization (WHO). But should we really be so quick to dismiss Magufuli and Rajoelina, and what they have to say? The point is not whether we agree or disagree with the Tanzanian and Madagascan approaches, but rather that, at the very least, there should be some proper, grown-up debate.
At the time of writing, Madagascar has reported 15 deaths due to Covid-19, while Magufuli declared Tanzania coronavirus-free in early June, after a total of 21 deaths. Now, you might want to challenge those figures, which is your prerogative, but you can’t automatically presume they are not accurate.
“I’m certain many Tanzanians believe that the corona disease has been eliminated by God,” Magufuli said. Now there is nothing more likely to trigger a virtue-signaling ‘anti-racist’ Western global public health ‘consensus’ follower than a black African leader defying the ‘party line’ on Covid and citing the Lord. Just look at Western press coverage of Magufuli’s stance: ‘”Africa’s ‘bulldozer’ runs into Covid and claims God is on his side” was the headline of one very hostile piece on Bloomberg.com.
Another journalist declared that Magufuli was “a strong contender for the most asinine coronavirus global leader.”
The oft-repeated claim in reports on Tanzania is that there’s been a cover-up. Right on cue, the US Embassy to Tanzania weighed in on May 13, claiming the risk of contracting Covid-19 in Dar es-Salaam was “extremely high.” The intimation was that the Tanzanian leader couldn’t possibly be telling the truth about Covid. But wasn’t that assumption, just a tiny bit, er, racist?
Another African leader who challenged the ‘consensus’ on Covid-19 was Burundi’s Pierre Nkurunziza. Burundi, which didn’t impose a lockdown, actually expelled the WHO’s team from the country in May, accusing it of “unacceptable interference.” On June 8, Nkurunziza died suddenly, aged 55. Yet again, this didn’t get too much coverage, save for some articles in the West claiming he had died of coronavirus, even though the official cause was given as a heart attack. African leaders can be lauded, but only if they toe the politically correct line set by self-proclaimed ‘anti-racist’ men in suits in the West, it seems.
And this colonial mindset permeates even the ‘anti-imperialist’ movement. A friend of mine told me he went on a demonstration against NATO’s attack on Libya in 2011. Some Libyans present had banners of their country’s president, Muammar Gaddafi. They were told to take them down by the non-Libyan organisers. That’s right: Africans weren’t allowed to display banners of their country’s leader at a march opposing the bombing of their country.
Rajoelina hit the nail on the head when he said the only reason the rest of the world has refused to treat what he believes is his country’s cure for the coronavirus with the urgency and respect it deserves is that the remedy comes from Africa.
Isn’t it ironic that, at a time when Western establishment figures are trying to show us every day how wonderfully ‘anti-racist’ they are, black voices outside the US and Britain are being ignored, even laughed at?
Only last week, UK Prime Minister Boris Johnson expressed his disapproval that Britain gave 10 times as much aid to Tanzania as “we do to the six countries of the Western Balkans, who are acutely vulnerable to Russian meddling.” How interesting that aid money sent to Tanzania gets questioned only now, after the country didn’t follow the script on Covid-19.
One wonders how many of the celebrities, politicians and pundits publicly expressing support for Black Lives Matters today have actually read the work of inspirational black African leaders such as Ghana’s Kwame Nkrumah and Tanzania’s Julius Nyerere, or, in fact, have even heard of them? I imagine the answer would be very few, if any.
The arrogant dismissal of voices from Africa that dare to defy Western-elite orthodoxy, and the failure to even consider the possibility that African leaders have got it right and their Western counterparts might have got it wrong, is in itself a form of neo-colonialism. And, lest we forget, Nkrumah described that as “the worst form of imperialism.”
If Black Lives Matter, then ‘politically incorrect’ black opinions ought to be listened to with respect, and not with a smug, superior facial expression before being loftily dismissed in the way a teacher might deal with a naughty child. But in this dumbed-down era in which many unthinkingly follow the dominant globalist narrative, it’s simpler for some to ‘take a knee’ and post a photo of themselves on social media doing so than it is to take a moment to see the bigger picture.
Neil Clark is a journalist, writer, broadcaster and blogger. His award winning blog can be found at http://www.neilclark66.blogspot.com. He tweets on politics and world affairs @NeilClark66
Mysterious Individual ‘Blocking Release of Docs That May Expose Epstein’s Rich & Powerful Friends’
Sputnik – 24.06.2020
Jeffrey Epstein’s alleged sex slave Virginia Roberts, now Giuffre, was previously embroiled in a prolonged legal battle with the financier’s close associate Ghislaine Maxwell that ended in 2017. However, a cache of documents in the case listing the names of the financier’s closest associates remains sealed.
An anonymous person dubbed “John Doe” is trying to prevent the release of documents related to the Roberts Giuffre-Maxwell defamation case, requested by attorney and former Harvard professor Alan Dershowitz, the Daily Mail reported.
The protective order over the documents in the case was signed by now deceased New York Judge Robert Sweet, preventing the public release of the names of people closely associated with Jeffrey Epstein and potentially involved in his sex trafficking scandal.
Dershowitz, who was a friend of the convicted sexual offender, is now fighting a separate defamation case against Epstein’s alleged victim Virginia Giuffre launched in November 2019. He is calling for the protective order to be removed, arguing that the documents contain materials that could be crucial for his own defamation lawsuit.
On Tuesday, a number of attorneys involved in the case held a teleconference to debate whether the protective order can be loosened upon Dershowitz’s request. According to the Daily Mail, legal teams representing Giuffre, Maxwell, and a mysterious “John Doe” have strongly opposed the move.
The person’s attorneys, Nicholas Lewin and Paul Krieger, said in a letter to the court, that the protocol over the release of Giuffre-Maxwell case materials, which are expected to be unveiled on a “rolling basis”, should not be derailed.
“This marks Dershowitz’s second – or, by some measures, third – attempt to make an end-run around this Court’s carefully constructed unsealing protocol. Just as the Court denied Dershowitz’s prior attempts, it should deny this one”, the attorneys argued, a position that was shared by Maxwell’s and Giuffre’s legal teams.
The defamation lawsuit against Epstein’s alleged “madame” Ghislaine Maxwell was brought by Giuffre in September 2015 and eventually settled under seal two years later.
The media is now speculating that the anonymous individual involved in the case could be a public figure who is not willing to be associated with the Epstein scandal. The disgraced financier died in his prison cell in August 2019, while awaiting trial on sex-trafficking charges following accusations by several women, including Virginia Roberts Giuffre. Throughout his business career, Epstein was associated with a number of powerful figures, including Hillary and Bill Clinton, Prince Andrew, Donald Trump, and many others. Roberts Giuffre claims that she was sex-trafficked to some of them, including British Prince Andrew and Alan Dershowitz, accusations both men have strongly denied.
‘Russiagate’ case against ex-Trump adviser Michael Flynn effectively OVER, as DC appeals court orders to close it
RT | June 24, 2020
An appeals court in Washington, DC, ruled that the case against President Trump’s one-time national security adviser, Michael Flynn, must end. The Justice Department had dropped charges against Flynn, but his case remained open.
In a ruling issued on Wednesday, the Washington DC Circuit Court of Appeals effectively ended the case against Flynn, ordering federal judge Emmet Sullivan to heed the Justice Department’s advice and close the case. Sullivan had attempted to keep the case active, even though the Justice Department dropped its charges against Flynn last month.
The appeals battle was a last-ditch showdown between Flynn and the Justice Department on one side, and Sullivan on the other. Though reporters as recently as last week reckoned the appeals court would side with Sullivan, they were proven wrong on Wednesday morning.
Of course, Sullivan may appeal again, but with the government and prosecution in agreement, his chances of breathing life into the Flynn case – ongoing for more than two years – is slim.
Appointed national security advisor following Trump’s election win in 2016, Flynn quickly became the first and most prominent White House official caught up in the FBI’s ‘Russiagate’ investigation. He was fired in early 2017 and later pleaded guilty to lying to FBI agents about his contacts with Russian Ambassador Sergey Kislyak.
However, the case was dropped last month, after it emerged that the charges against him were baseless.
Before he was interviewed by FBI agents in January 2017, FBI brass knew they had “no derogatory information” on the retired General, yet then-FBI Director James Comey ordered the interview to proceed regardless, breaching agency protocol. Disgraced FBI agent Peter Strzok urged his superiors to keep the case against Flynn open, and plotted with other agents to “get him to lie” during the interview. Furthermore, Strzok and former FBI lawyer Lisa Page edited the transcript of the interview to incriminate Flynn.
All of this information was revealed last month, when acting Director of National Intelligence Richard Grenell declassified a trove of ‘Russiagate’ documents. According to the document dump, a host of Obama administration officials dug into Flynn’s intelligence records as the FBI were attempting to entrap him in the interview.
President Trump, who has long accused the FBI and Obama administration of orchestrating a plot to take down his presidency, retweeted a call from his son last week for Flynn to “sue the FBI and it’s corrupt actors for all they’re worth.”
Let’s fact-check Reuters: they say DNA vaccines don’t change your genetic makeup—true or false?
By Jon Rappoport | June 23, 2020
As my readers know, I’ve been reporting on new types of technology that could be used in a coming COVID-19 vaccine—and warning about the consequences.
One such technology is: DNA vaccines. They would alter recipients’ genetic makeup permanently.
But Reuters has seen fit to claim: “A future COVID-19 [DNA] vaccine will not genetically modify humans.” This comes from their “fact-check team” — May 18, 2020: “False claim: A COVID-19 vaccine will genetically modify humans.”
To reach this conclusion, Reuters cites two people: “Mark Lynas, a visiting fellow at Cornell University’s Alliance for Science group”, and “Dr. Paul McCray, Professor of Pediatrics, Microbiology, and Internal Medicine at the University of Iowa.”
I have cited the New York Times, March 10, 2015, “Protection Without a Vaccine.” Here are quotes from the Times article:
“By delivering synthetic genes into the muscles of the [experimental] monkeys, the scientists are essentially re-engineering the animals to resist disease.”
“’The sky’s the limit,’ said Michael Farzan, an immunologist at Scripps and lead author of the new study.”
“The first human trial based on this strategy — called immunoprophylaxis by gene transfer, or I.G.T. — is underway, and several new ones are planned.” [That was five years ago.]
“I.G.T. is altogether different from traditional vaccination. It is instead a form of gene therapy. Scientists isolate the genes that produce powerful antibodies against certain diseases and then synthesize artificial versions. The genes are placed into viruses and injected into human tissue, usually muscle.”
[Here is the punch line] “The viruses invade human cells with their DNA payloads, and the synthetic gene is incorporated into the recipient’s own DNA. If all goes well, the new genes instruct the cells to begin manufacturing powerful antibodies.”
The Times article taps Dr. David Baltimore for an opinion:
“Still, Dr. Baltimore says that he envisions that some people might be leery of a vaccination strategy that means altering their own DNA, even if it prevents a potentially fatal disease.”
So it’s a battle of the experts. The two men Reuters cited, versus the Times’ David Baltimore.
I don’t hold up the scientific work of any of these men for great acclaim. I’m only interested in which man knows whether a DNA vaccine would permanently alter the genetic makeup of every recipient’s DNA.
David Baltimore is a Nobel Laureate (1975, in Physiology/Medicine), and the past president of the American Association for the Advancement of Science (1997-2006). He’s one of the most famous scientists in the world.
I’m betting Reuters would happily trade their unknown experts for Baltimore, if he would side with their claim. Perhaps they’ll now approach him, and perhaps he’ll change his mind. But the NY Times has him on the record, in 2015, admitting that DNA vaccines do alter genetic makeup.
World famous mainstream experts don’t readily admit this sort of thing out in the open, unless they’re stating the obvious.
The verdict on the Reuters fact-check team? Fact-checkers checked the wrong box.
Final point for the moment: Researchers are fond of saying their genetic technologies are quite safe. This a bald-faced lie. Claiming, for example, that a DNA COVID vaccine would alter humans’ genetic makeup in entirely predictable and harmless ways is like saying a car without brakes, doing a hundred miles an hour, set loose on a highway during rush hour, would create no damage whatsoever.
SOURCES:
nytimes.com/2015/03/10/health/protection-without-a-vaccine.html
“Deadly” Hydroxychloroquine (HCQ) to treat Covid 19: How the World’s Top Medical Journals, The Lancet and NEJM, Were Cynically Exploited by Big Pharma
By Elizabeth Woodworth | Global Research | June 14, 2020
Abstract and Background
A publishing scandal recently erupted around the use of the anti-malarial drug hydroxychloroquine (HCQ) to treat Covid 19. It is also known as quinine and chloroquine, and is on the WHO list of essential medicines.[i]
The bark of the South American quina-quina tree has been used to treat malaria for 400 years.[ii] Quinine, a generic drug costing pennies a dose, is available for purchase online. In rare cases it can cause dizziness and irregular heartbeat.[iii]
In late May, 2020, The Lancet published a four-author study claiming that HCQ used in hospitals to treat Covid-19 had been shown conclusively to be a hazard for heart death. The data allegedly covered 96,000 patients in 671 hospitals on six continents.[iv]
After the article had spent 13 days in the headlines, dogged by scientific objections, three of the authors retracted it on June 5.[v]
Meanwhile, during an expert closed-door meeting leaked May 24 in France, The Lancet and NEJM editors explained how financially powerful pharmaceutical players were “criminally” corrupting medical science to advance their interests.
*
On May 22, 2020, the time-honoured Lancet [vi]– one of the world’s two top medical journals – published the stunning claim that 671 hospitals on six continents were reporting life-threatening heart rhythms in patients taking hydroxychloroquine (HCQ) for Covid-19.
The headlines that followed were breath-taking.
Although wider access to the drug had recently been urged in a petition signed by nearly 500,000 French doctors and citizens,[vii] WHO and other agencies responded to the article by immediately suspending the clinical trials that may have cleared it for use.
North American headlines did not mention that HCQ has been on the WHO list of essential drugs since the list began in 1977. Nor did they mention an investigative report on the bad press that hydroxychloroquine had been getting prior to May 22, and how financial interests had been intersecting with medicine to favour Gilead’s new, more expensive drug, Remdesivir.[viii]
The statistics behind the headlines
As a Canadian health sciences librarian who delivered statistics to a large public health agency for 25 years, I sensed almost immediately that the article had to be flawed.
Why? Because health statistics are developed for different purposes and in different contexts, causing them to exist in isolated data “stovepipes.”[ix] Many health databases, even within a single region or country, are not standardized and are thus virtually useless for comparative research.
How, I wondered, could 671 hospitals worldwide, including Asia and Africa, report comparable treatment outcomes for 96,000 Covid patients? And so quickly?
The Lancet is strong in public health and surely suspected this. Its award-winning editor-in-chief, Dr. Richard Horton, has been in his job since 1995.[x]
So how could the damning HCQ claims have been accepted? Here is what I discovered.
The honour system in medical publishing
To some extent, authors submitting articles to medical journals are on the honour system, in which cited databases are trusted by the editors, yet are available for inspection if questioned.[xi]
On May 28, an open letter from 200 scientists to the authors and The Lancet requested details of the data and an independent audit. The letter was “signed by clinicians, medical researchers, statisticians, and ethicists from across the world.”[xii]
The authors declined to supply the data, or even the hospital names. Meanwhile, investigative analysis was showing the statistics to be deeply flawed.[xiii][xiv]
If this were not enough, the lead author was found to be in a conflict of interest with HCQ’s rival drug, Remdesivir:
“Dr. Mandeep Mehra, the lead co-author is a director at Brigham & Women’s Hospital, which is credited with funding the study. Dr. Mehra and The Lancet failed to disclose that Brigham Hospital has a partnership with Gilead and is currently conducting two trials testing Remdesivir, the prime competitor of hydroxychloroquine for the treatment of COVID-19, the focus of the study.”[xv]
In view of the foregoing, the article was retracted by three of its authors on June 5.
How did this fraud get past The Lancet reviewers in the first place?
The answer emerges from what has remained an obscure French interview, although it has been quoted in the alternative media.[xvi]
On May 24, a closed-door Chatham House expert meeting about Covid included the editors-in-chief of The Lancet and the NEJM. Comments regarding the article were leaked to the French press by a well-known health figure, Dr. Philippe Douste-Blazy,[xvii] who felt compelled to blow the whistle.
His resulting BFM TV interview was posted to YouTube with English subtitles on May 31,[xviii] but it was not picked up by the English-speaking media.
These were The Lancet editor Dr. Richard Horton’s words, as reported by Dr. Douste-Blazy:
“If this continues, we are not going to be able to publish any more clinical research data because pharmaceutical companies are so financially powerful today, and are able to use such methodologies as to have us accept papers which are apparently methodologically perfect, but which, in reality, manage to conclude what they want to conclude.” [xix]
Doust-Blazy made his own comments on Horton’s words:
“I never thought the boss of The Lancet could say that. And the boss of the New England Journal of Medicine too. He even said it was ‘criminal’. The word was used by them.”[xx]
The final words in Doust-Blazy’s interview were:
“When there is an outbreak like Covid, in reality, there are people like us – doctors – who see mortality and suffering. And there are people who see dollars. That’s it.”[xxi]
The scientific process of building a trustworthy knowledge base is one of the foundations of our civilization. Violating this process is a crime against both truth and humanity.
Evidently the North American media does not consider this extraordinary crime to be worth reporting.
Notes
[i] World Health Organization. “World Health Organization Model List of Essential Medicines, 21st ed.”, WHO, 2019, pp. 24, 25, 53 (https://www.who.int/medicines/publications/essentialmedicines/en/).
[ii] Jane Achan, et al., “Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria,” Malaria Journal, 24 May 2011 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121651/).
[iii] WebMD, “Quinine Sulfate” (https://www.webmd.com/drugs/2/drug-869/quinine-oral/details).
[iv] The Lancet, “RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis, by Mandeep R. Mehra et al,” Lancet, 5 June 2010 (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31180-6/fulltext).
[v] Ibid.
[vi] Famous weekly British medical journal, founded in 1823.
[vii] Lee Mclaughlan, “Covid-19 France: petition for wider chloroquine access,” 6 April 2020 (https://www.connexionfrance.com/French-news/Time-wasted-over-use-of-choroquine-coronavirus-drug-says-petition-by-former-French-health-minister).
[viii] Sharyl Attkisson, “Hydroxychloroquine,” Full Measure, 18 May 2020 (https://www.youtube.com/watch?v=zB-_SV-y11Y). Attkisson is a five-time Emmy Award winner (https://en.wikipedia.org/wiki/Sharyl_Attkisson).
[ix] See “Stovepiping,” (https://en.wikipedia.org/wiki/Stovepiping) (accessed June 12, 2020).
[x] Dr. Horton’s career, professionalism, and awards are shown at https://en.wikipedia.org/wiki/Richard_Horton_(editor)(accessed June 12, 2020).
[xi] The Lancet and NEJM editors could not be expected to comb through data from 671 hospitals to verify their accuracy – especially when submitted by four doctors.
[xii] The full-text letter and signatories appear at https://zenodo.org/record/3862789#.XuQiNmYTGhM
[xiii] Melissa Davey, “Questions raised over hydroxychloroquine study which caused WHO to halt trials for Covid-19,” The Guardian, 28 May 2020 (https://www.theguardian.com/science/2020/may/28/questions-raised-over-hydroxychloroquine-study-which-caused-who-to-halt-trials-for-covid-19).
[xiv] Melissa Davey et al, “Surgisphere: governments and WHO changed Covid-19 policy based on suspect data from tiny US company,” The Guardian, 3 June 2020 (https://www.theguardian.com/world/2020/jun/03/covid-19-surgisphere-who-world-health-organization-hydroxychloroquine).
[xv] 1. Alliance for Human Research Protection, “The Lancet Published a Fraudulent Covid-19 Study,” 2 June 2020 (https://ahrp.org/the-lancet-published-a-fraudulent-study-editor-calls-it-department-of-error/).
- Brigham Health, “Two Remdesivir Clinical Trials Underway at Brigham and Women’s Hospital,” 30 March 2020 (https://www.brighamhealthonamission.org/2020/03/26/two-remdesivir-clinical-trials-underway-at-brigham-and-womens-hospital/).
[xvi] Vera Sharav, “Editors of The Lancetand the New England Journal of Medicine: Pharmaceutical Companies are so Financially Powerful They Pressure us to Accept Papers,” Health Impact News, 5 June 2020
[xvii] Dr. Philippe Douste-Blazy, MD, is a cardiologist, former French Health Minister; 2017 candidate for Director at WHO; and former Under-Secretary-General of the United Nations. See also: https://en.wikipedia.org/wiki/Philippe_Douste-Blazy.
[xviii] “(Eng Subs) Hydroxychloroquine Lancet Study: Former France Health Minister blows the whistle,” BFM TV, 31 May 2020 (https://www.youtube.com/watch?time_continue=2&v=ZYgiCALEdpE&feature=emb_logo).
[xix] Ibid.
[xx] Ibid.
[xxi] Ibid.
Copyright © Elizabeth Woodworth, Global Research, 2020
Bolton’s statements on Trump-Kim summit are ‘distorted,’ Seoul says
RT | June 22, 2020
South Korea said on Monday that accounts by former US National Security Advisor John Bolton of discussions between leaders of the United States and the two Koreas in his upcoming book are inaccurate and distorted.
Reports have cited Bolton as writing that South Korean President Moon Jae-in, who is keen to improve relations with Pyongyang, had raised unrealistic expectations with both the North’s leader, Kim Jong-un, and US President Donald Trump, for his own “unification” agenda.
“It does not reflect accurate facts and substantially distorts facts,” South Korea’s national security adviser, Chung Eui-yong, said in a statement referring to Bolton’s description of the consultations.
Chung did not elaborate on specific areas but said the publication set a “dangerous” precedent. “Unilaterally publishing consultations made based on mutual trust violates the basic principles of diplomacy and could severely damage future negotiations,” Reuters quoted him as saying.
Financial Conflicts & the Retracted COVID Research
Lead author, paid by drug companies, gives the all-clear to products those companies sell. World’s leading medical journal fails transparency test.
By Donna Laframboise | Big Picture News | June 22, 2020
Mandeep Mehra is a professor at Harvard Medical School, and the medical director of a Boston hospital department. That city being a coronavirus hotspot, life hasn’t been normal there for some time.
He’s also the lead author of two COVID-19 research papers that were retracted shortly after being published in prestigious medical journals. Lancet boss Richard Horton calls the one published in his journal a “monumental fraud.”
The other, which has received less attention, appeared in the New England Journal of Medicine (NEJM). Titled Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19, it runs to seven pages and was retracted because its authors now admit the data on which it relies cannot be validated.
During this pandemic, physicians have been desperate for information to help guide their decisions. Eric Rubin, editor-in-chief of the NEJM, recently explained to the New York Times,
I’m an infectious disease doctor, I treat Covid-19 patients. I’ve been in the hospital recently treating patients, and we have no idea what to do. I’m the primary driver at the journal of saying, ‘We have to get data out there that people can use.’ [bold added]
Many hypotheses have been advanced. Many questions remain unanswered. For example, there’s uncertainty about whether some widely prescribed medications might be complicating the picture. Are people who take high blood pressure pills – ACE inhibitors and ARBs (angiotensin receptor blockers) – at higher risk? Should they switch to alternatives until the pandemic is over (see here, here, and here)?
Similarly, should people on cholesterol-lowering statins follow advice published in the British Medical Journal and stop taking these drugs if they develop a serious case of COVID-19? Statins are, after all, prescribed for preventative purposes, to help avert heart problems longer term.
Mehra’s paper claimed to have examined patient records from three continents and to have found no evidence that any of these drugs increase the death rate of those who had heart issues prior to the coronavirus. Indeed, it declares that “the use of ACE inhibitors, and the use of statins were associated with a better chance of survival” in women.
But even if this data was 100% reliable, there would still be two enormous problems with this research:
#1: The lead author has financial ties to companies that sell those drugs.
#2: Neither the authors nor the journal informed us of this salient fact up front, in a transparent manner.
The paper reports, on page 1, that the research was “Funded by the William Harvey Distinguished Chair in Advanced Cardiovascular Medicine at Brigham and Women’s Hospital.”
Mehra’s Harvard e-mail address also appears on page 1. Readers are told that’s where reprint requests should be addressed (reprints are frequently distributed to third party doctors by drug companies as marketing material, and can be a considerable source of revenue for medical journals).
At the very end of the paper, on page 7, in fine print, we’re reminded that the research was supported by the William Harvey Distinguished Chair. Only then are we advised that “Disclosure forms by the authors are available with the full text of this article at NEJM.org.”
One must go to the trouble of tracking down the online version of the paper, and downloading that separate 16-page PDF, to discover the lead author has a serious conflict of interest. There, on page 12, we read:
Dr. Mehra reports personal fees from Abbott, personal fees from Medtronic, personal fees from Janssen, personal fees from Mesoblast , personal fees from Baim Institute for Clinical Research, personal fees from Portola, personal fees from Bayer, personal fees from Triple Gene, personal fees from Leviticus, personal fees from NupulseCV, personal fees from FineHeart, other from Riovant, outside the submitted work;. [sic, bold added]
Abbott Laboratories sells statins and ACE inhibitors. The company is described as a “top key player,” a “major giant,” and a “leading player” in those global marketplaces.
Likewise, Bayer AG is a major global player in the ARB market.
So a lead author who has financial relationships with two companies that sell certain classes of drugs took the time, during a pandemic, to give those drugs an all-clear.
On it’s website, the New England Journal of Medicine calls itself “the world’s leading medical journal.” Why did it choose to bury this vital piece of information?
Retracted Papers Written by Journal VIP
By Donna Laframboise | Big Picture News | June 17, 2020
The lead author of two retracted COVID-19 papers is editor-in-chief of an Elsevier medical journal.
Earlier this month, two high-profile research papers were retracted on the same day. One, published in The Lancet, had concluded that coronavirus patients treated with malaria drugs were more likely to die. Published on May 22, it was officially withdrawn 13 days later.
Another, published in the New England Journal of Medicine, found no evidence that widely prescribed medications increase the death rate of hospitalized COVID-19 patients with pre-existing heart problems.
The lead author in both instances was Mandeep Mehra, a professor of medicine at Harvard Medical School, and the person in charge of the Heart and Vascular Center at Boston’s Brigham and Women’s Hospital.
The second listed author was Sapan Desai. An online bio describes him as an “internationally-recognized double board certified vascular surgeon.” Desai is the founder of Surgisphere Corporation, a data analytics firm which claimed to have acquired 96,000 highly-detailed electronic medical records of COVID-19 patients from 671 hospitals on six continents.
The Lancet paper’s dramatic findings interrupted drug trials and changed government policy in multiple countries. It also increased the anxiety of coronavirus patients who’d been participating in those trials.
But six days after the paper appeared, more than 100 “clinicians, medical researchers, statisticians, and ethicists” addressed an open letter to the authors, and to Lancet editor-in-chief Richard Horton, questioning the integrity of the cited data.
Why were the hospitals which supplied this data not identified? Why weren’t standard statistical practices employed? Why no ethics review? Why didn’t the paper invite other researchers to examine for themselves the underlying data and computer code?
According to these experts, the medication dose sizes discussed were odd, drug ratios sounded “implausible,” the Australian data was obviously erroneous, and the African data seemed “unlikely.”
Yet none of The Lancet‘s peer-reviewers apparently noticed. “In the interests of transparency,” said the signatories of the open letter, “we also ask The Lancet to make openly available the peer review comments that led to this manuscript to be accepted for publication [sic].”
An article in the New York Times says these events “have alarmed scientists worldwide who fear that the rush for research on the coronavirus has overwhelmed the peer review process.” Lancet editor Horton, it reports, now describes the retracted paper as a “fabrication” and “a monumental fraud.”
A headline in the UK Guardian says The Lancet has made one of the biggest retractions in modern history. How, asks the article that follows,
did a paper of such consequence get discarded like a used tissue by some of its authors only days after publication? If the authors don’t trust it now, how did it get published in the first place?…the sad truth is peer review in its entirety is struggling…
Neither of those articles mentioned an astonishing fact. Lead author Mehra is himself the editor-in-chief of The Journal of Heart and Lung Transplantation. Part of Elsevier’s scholarly publishing empire, this monthly journal hires editors for five-year terms. Mehra’s second term is coming to end, and last year the search for a replacement began.
As the posted job description explains, the editor-in-chief is responsible for overseeing the peer review of papers submitted to that journal. He or she is constantly evaluating research, sorting solid science from weak science. The new editor-in-chief, we’re told, must have “a demonstrated understanding of statistics and statistical methods.”
So how could a man who has spent the past 10 years in such a role have authored this pair of retracted papers? How could anyone with any statistical sophistication have taken such dodgy data at face value?
“No matter which way you examine the data, use of these [malaria] drug regimens did not help,” Mehra declared in a press release when The Lancet paper was published. But it now appears he didn’t directly examine the data at all. On the day the paper was retracted, he explained in a subsequent statement:
Dr. Desai, who served as a co-author and whose team maintained this observational database, conducted various analyses. As first author, these were provided to me, and on the basis of these analyses, we published two peer-reviewed papers…
In other words, this longtime editor-in-chief took someone else’s word for it. He failed to ask elementary questions. He took it on faith that the analyses had been properly conducted. Mehra continued:
It is now clear to me that in my hope to contribute this research during a time of great need, I did not do enough to ensure that the data source was appropriate for this use. For that, and for all the disruptions – both directly and indirectly – I am truly sorry.
This, ladies and gentlemen, is the vaunted peer review system in action. Naive trust. Blind faith. By Mehra. By The Lancet. By the New England Journal of Medicine. Even when real lives, right now, hang in the balance.
Four years ago, I authored a report demonstrating that peer review is merely a sniff test. Typically performed by unpaid volunteers, it’s based on wholly subjective criteria, and is highly influenced by the pre-existing beliefs of those doing the reviewing. My report contains this paragraph:
In 2014, Science announced measures to provide deeper scrutiny of statistical claims in the research it publishes. John Ioannidis, the author of a seminal 2005 paper asserting that most published research findings are false, called this announcement “long overdue”. In his opinion, statistical review has become more important than traditional peer review for a “majority of scientific papers”.
In many places, statistical review still doesn’t occur. Even in our current situation, when COVID-19 research has the power to halt drug trials and change history, the vetting process at medical journals is a joke.




